DiLab Revenue and Competitors
Estimated Revenue & Valuation
- DiLab's estimated annual revenue is currently $5.9M per year.
- DiLab's estimated revenue per employee is $155,000
Employee Data
- DiLab has 38 Employees.
- DiLab grew their employee count by 15% last year.
DiLab's People
| Name | Title | Email/Phone |
|---|
DiLab Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is DiLab?
DiLab - inventing the future of Automated Blood Sampling. The DiLab AccuSampler is a fully automated system for blood sampling in tethered, freely-moving research animals. Since 2011 DiLab® is a part of VeruTech AB. DiLab was founded 1983 by Hans Axel Hansson (CEO, VeruTech AB). During the 90's the pharmaceutical company Novo Nordisk A/S in Denmark approched DiLab with a project. The aim was to build an instrument that automatically could handle the collection of blood instead of manual sampling. The result became the AccuSampler® and with this our first steps was taken in the ABS business (Automated Blood Sampling).
keywords:N/A
N/A
Total Funding
38
Number of Employees
$5.9M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.2M | 38 | 3% | N/A |
#2 | $5.9M | 38 | -25% | $2M |
#3 | N/A | 38 | 31% | N/A |
#4 | $4M | 38 | -19% | $26.2M |
#5 | $4M | 38 | -7% | $51.1M |